Concepedia

Laura A. McAllister

LA

Statistics

Publications

26

Citations

1.2K

H-Index

21

Active since

2003

Affiliations

Pfizer (United States)(Current)

Scripps Research Institute

University of Glasgow

University of Manchester

Laura A. McAllister is an author at Pfizer (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2003–2025

26

Publications

26

Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections

Justin I. Montgomery, Matthew F. Brown, Usa Reilly et al. · Journal of Medicinal Chemistry · 2012 · 97 citations · Full text

, , +10

Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia

Amy B. Dounay, Marie Anderson, Bruce M. Bechle et al. · ACS Medicinal Chemistry Letters · 2012 · 90 citations · Full text

, , +13

Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation

Laura A. McAllister, Christopher R. Butler, Scot Mente et al. · Journal of Medicinal Chemistry · 2018 · 80 citations · Full text

, , +17

Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase

Christopher R. Butler, Elizabeth Beck, Anthony R. Harris et al. · Journal of Medicinal Chemistry · 2017 · 78 citations · Full text

, , +16

Synthesis, Characterization and Development of a High-Throughput Methodology for the Discovery of Botulinum Neurotoxin A Inhibitors

Grant E. Boldt, Jack P. Kennedy, Mark S. Hixon et al. · Journal of Combinatorial Chemistry · 2006 · 72 citations · Full text

, , +14

1–5 of 26